Antibacterial activity of Syzygium aromaticum (clove) against uropathogens producing ESBL, MBL, and AmpC beta-lactamase: Are we close to getting a new antibacterial agent?

Antibacterial activity of Syzygium aromaticum (clove) against uropathogens producing ESBL, MBL, and AmpC beta-lactamase: Are we close to getting a new antibacterial agent?

Introduction: The present study was done to access the antibacterial activity of clove (Syzygium aromaticum) against extended-spectrum beta-lactamase (ESBL), metallo-beta-lactamase (MBL), and AmpC beta-lactamase-producing gram-negative bacteria causing urinary tract infection. Methods: A total of 22...

Full description

Bibliographic Details
Main Authors:	Sameer S Faujdar, Dakshina Bisht, Amisha Sharma
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Journal of Family Medicine and Primary Care
Subjects:	extended-spectrum β-lactamases metallo-beta-lactamase and ampc beta-lactamase syzygium aromaticum (clove) urinary tract infection uropathogens
Online Access:	http://www.jfmpc.com/article.asp?issn=2249-4863;year=2020;volume=9;issue=1;spage=180;epage=186;aulast=Faujdar

Similar Items

Antibacterial potential of neem (Azadirachta indica) against uropathogens producing beta-lactamase enzymes: A clue to future antibacterial agent?
by: Sameer Singh Faujdar, et al.
Published: (2020-01-01)

Antibacterial activity of clove (Syzygium aromaticum) and cinnamon (Cinnamomum burmannii) essential oil against extended-spectrum β-lactamase-producing bacteria
by: Elgio Venanda Ginting, et al.
Published: (2021-08-01)

Phenotypic Detection of ESBL, MBL (IMP-1), and AmpC Enzymes, and Their Coexistence in Enterobacter and Klebsiella Species Isolated FromClinical Specimens
by: Zahra Shahandeh, et al.
Published: (2016-05-01)

Prevalence of extended-spectrum beta-lactamases, AmpC beta-lactamase, and metallo-beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii in an intensive care unit in a tertiary care hospital
by: Varun Goel, et al.
Published: (2013-01-01)

Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial
by: Adam G. Stewart, et al.
Published: (2021-04-01)

A study on detection of extended-spectrum beta-lactamases (ESBLs) and comparison of various phenotypic methods of AmpC detection in Pseudomonas aeruginosa from various clinical isolates in a tertiary care teaching hospital
by: Subbalakshmi Easwaran, et al.
Published: (2016-01-01)

Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea
by: Hae Suk Cheong, et al.
Published: (2016-11-01)

Molecular detection of TEM and AmpC (Dha, mox) broad spectrum β-lactamase in clinical isolates of Escherichia coli
by: Soltan Dallal MM, et al.
Published: (2010-09-01)

Virulence characterization of Klebsiella pneumoniae and its relation with ESBL and AmpC beta-lactamase associated resistance
by: Elghar Soltani, et al.
Published: (2020-04-01)

Estudo fenotípico e molecular de beta-lactamases de espectro estendido e AmpC em enterobactérias isoladas de pacientes com suspeita de meningite
by: Leonardo Neves de Andrade
Published: (2008)

Estudo fenotípico e molecular de beta-lactamases de espectro estendido e AmpC em enterobactérias isoladas de pacientes com suspeita de meningite
by: Andrade, Leonardo Neves de
Published: (2008)

ESBL, MBL and Ampc β Lactamases Producing Superbugs – Havoc in the Intensive Care Units of Punjab India
by: Loveena Oberoi, et al.
Published: (2013-01-01)

Controversies about Extended-Spectrum and AmpC Beta-Lactamases
by: Kenneth S. Thomson
Published: (2001-04-01)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020-06-01)

Evaluation of phenotypic tests for the detection of AmpC beta-lactamase in clinical isolates of Escherichia coli
by: Deepika Handa, et al.
Published: (2013-01-01)

Rapid Detection of Extended-Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases in Enterobacterales: Development of a Screening Panel Using the MALDI-TOF MS-Based Direct-on-Target Microdroplet Growth Assay
by: Carlos L. Correa-Martínez, et al.
Published: (2019-01-01)

Lipid profile, antiradical power and antimicrobial properties of Syzygium aromaticum oil
by: M. F. Ramadan, et al.
Published: (2013-12-01)

Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt
by: Ebtisam S. Mohamed, et al.
Published: (2020-12-01)

An Investigation of the Prevalence of AmpC-producing Pseudomonas aeruginosa in Clinical Samples in Zahedan City, Iran
by: Javad Adabi, et al.
Published: (2017-06-01)

Detection of Ampc and Extended-Spectrum Beta-Lactamases in Clinical Isolates of Pseudomonas Aeruginosa from Patients with Cystic Fibrosis
by: Roya Rafiee, et al.
Published: (2016-05-01)

Green Microwave-assisted Synthesis of ZnO-Ag Nanocomposite using Clove Oil (Syzygium aromaticum L.) and Its Bioactivity against Staphylococcus aureus
by: Elvina Dhiaul Iftitah, et al.
Published: (2020-08-01)

Antibiotic Resistance and Phenotypic and Genotypic Detection of AmpC Beta-Lactamases among Klebsiella pneumoniae Isolates from Kermanshah Medical Centers
by: Alisha Akya, et al.
Published: (2019-01-01)

Molecular Basis of the Therapeutical Potential of Clove (<i>Syzygium aromaticum</i> L.) and Clues to Its Anti-COVID-19 Utility
by: Caterina Vicidomini, et al.
Published: (2021-03-01)

Antimicrobial Resistance Genes and Diversity of Clones among ESBL- and Acquired AmpC-Producing <i>Escherichia coli</i> Isolated from Fecal Samples of Healthy and Sick Cats in Portugal
by: Isabel Carvalho, et al.
Published: (2021-03-01)

Phenotypic detection of Metallo- and AmpC β-lactamases producing strains of P. aeruginosa in the state of Himachal Pradesh (India)
by: Naveen Minhas, et al.
Published: (2015-10-01)

Extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniaei: A Multi-centric Study Across Karnataka
by: Sridhar PN Rao, et al.
Published: (2014-01-01)

Epidemiology of extended spectrum β-lactamase, AmpC and class A carbapenemases-producing organisms isolated at San Camillo Hospital of Treviso (Italy) between April 2012 and March 2014
by: Margherita Scapaticci, et al.
Published: (2016-03-01)

Identification of extended spectrum beta lactamases, AmpC and carbapenemase production among isolates of Escherichia coli in North Indian tertiary care centre
by: Uma Chaudhary, et al.
Published: (2018-04-01)

Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing Saccharomyces to a Mixture of Lactobacillus, Bifidobacterium, and Saccharomyces
by: Grégoire Wieërs, et al.
Published: (2021-03-01)

Carbapenemases as factors of Resistance to Antibacterial Drugs
by: A. V. Nevezhina
Published: (2021-01-01)

Antibiotic resistance profile and co-production of extended spectrum beta lactamases and AmpC in Acinetobacter spp. in a level 1 trauma center from India
by: Priyam Batra, et al.
Published: (2019-04-01)

Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus
by: Emrah Ruh, et al.
Published: (2019-06-01)

Frequency of AmpC Beta-Lactamase Genes in Escherichia Coli Genera of Urinary Tract Infection Isolated from Patients Admitted to Internal Wards of Yazd Hospitals, Iran
by: Ali Mansouri, et al.
Published: (2017-12-01)

Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy
by: Trupti Bajpai, et al.
Published: (2014-01-01)

Extended Spectrum Beta-Lactamase (ESBL) Producing Uropathogens in Pregnancy
by: Yogendra Shelke, et al.
Published: (2019-11-01)

Unequivocal Identification of 1-Phenylethyl Acetate in Clove Buds (syzygium aromaticum (L.) Merr. & L.M.Perry) and Clove Essential Oil
by: Klaus Gassenmeier, et al.
Published: (2017-06-01)

Co-production of ESBL and AmpC β-Lactamases in Clinical Isolates of A. baumannii and A. lwoffii in a Tertiary Care Hospital From Northern India
by: Pooja Singla, et al.
Published: (2014-04-01)

The Protective Effects of Syzygium aromaticum Essential Oil Extract against Methotrexate Induced Hepatic and Renal Toxicity in Rats
by: Duaa Abd Al-azem, et al.
Published: (2019-03-01)

The Survey for AmpC beta-lactamase Production and Characterization of Antibiotic Resistance Profile in Clinical Isolates of Klebsiella oxytoca
by: Mahbobeh Nassari, et al.
Published: (2016-05-01)

Assessment of AmpC Beta-Lactamase Genes among Clinical Escherichia coli Isolates
by: Hedroosha Molla Agha Mirzaeie, et al.
Published: (2015-09-01)